VTGN - Vistagen Therapeutics • Financials

Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.

Complete and updated financials table with all primary indicators: Net Income, Revenue, EBITDA, Margin, ROE, Dividends

Year	Revenue	EBITDA	Net Inc	Net Mrg	EPS	Equity	ROE	Net Debt Aj	ND/EBITDA Aj	OCF Aj	Capex	FCF	Free Aj	Buyback	Dividend	Payout	DY
03/2017	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
03/2018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
03/2019	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
03/2020	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
03/2021	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
03/2022	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
03/2023	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
03/2024	1	-33	-	L	L	114	L	-119	-	-28	-0	128	-28	0	0	-	-
03/2025	0	-56	-	L	L	70	L	-80	-	-46	-0	3	-47	0	0	-	-
03/2026	1	-72	-	L	L	36	L	-45	-	-70	-0	31	-71	0	0	-	-

To see all financials—including updated, you must be Premium.